Research Articles | Page 89 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis Feb 2015 Ann Hematol aplastic anemia
Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine. Jun 2013 Ann Hematol myelodysplastic syndromes (MDS)
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function Apr 2014 Ann Hematol myelodysplastic syndromes (MDS)
Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: is eculizumab indicated? Jul 2012 Ann Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Myelodysplastic syndromes: pathophysiology, clinical and biological features Dec 2015 Ann Biol Clin (Paris) myelodysplastic syndromes (MDS)
Spontaneous remision of aplastic anemia occurring during a pregnancy Aug 2012 Ann Biol Clin (Paris) aplastic anemia
Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes Apr 2016 Anemia myelodysplastic syndromes (MDS)
Myelodysplastic Syndromes: 2021 update on Diagnosis, Risk-stratification and Management Aug 2020 American Journal of Hematology myelodysplastic syndromes (MDS)
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes Nov 2019 American Journal of Hematology myelodysplastic syndromes (MDS)
Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab Aug 2020 American Journal of Hematology paroxysmal nocturnal hemoglobinuria (PNH)